Trex makes RSNA exhibit debut
X-ray conglomerate Trex Medical of Danbury, CT, will exhibit forthe first time at an RSNA meeting, with sections of its boothdevoted to the four companies in the Trex universe: Lorad, BennettX-Ray, Continental X-Ray, and XRE. Highlights will include
X-ray conglomerate Trex Medical of Danbury, CT, will exhibit forthe first time at an RSNA meeting, with sections of its boothdevoted to the four companies in the Trex universe: Lorad, BennettX-Ray, Continental X-Ray, and XRE.
Highlights will include Lorad's flagship M-IV mammography system,which began shipping in August, according to Hal Kirshner, presidentand CEO. The system debuted at the 1995 RSNA conference.
Bennett will introduce Contour Plus, the next generation ofits Contour mammography system, which has been upgraded to takepower from the 220-volt outlets common in hospitals, accordingto Bennett president Walter Schneider. In addition to ContourPlus, Bennett will introduce Profile, a new work-in-progress mid-rangefreestanding mammography system designed to fit into smaller roomsthan Contour. Continental will debut a new premium radiography/fluoroscopysystem.
Trex continues to make headway in its efforts to develop afull-field digital mammography detector that can be retrofittedto M-IV, Contour, and Profile systems, according to Kirshner.Trex installed its latest preproduction prototypes at four clinicalsites in September, and will show images from the sites in itsbooth. Data from the sites will be used to support Trex's 510(k)regulatory filing for the system, which should be filed by theend of this year.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
